Navigation Links
Vomaris Announces initiation of study with Walter Reed National Military Medical Center's Combat Wound Initiative
Date:2/19/2013

CHANDLER, Ariz., Feb. 19, 2013 /PRNewswire/ -- Vomaris Innovations, Inc., a leading edge regenerative medicine company focusing on wound care with bioelectric technology, is pleased to announce the initiation of a new study with Walter Reed National Military Medical Center.

The objective of the study, funded by the Henry M. Jackson Foundation for the Advancement of Military Medicine, is the assessment of the clinical efficacy of a bioelectric dressing (Procellera®) in conjunction with standard-of-care on the healing rate of chronic soft tissue wounds compared with standard-of-care alone.

In this 50-subject study, the primary endpoint for efficacy will be the rate of healing (healing trajectory) in the treatment group compared to that of the control group, during the 12-week treatment study period.  It is hypothesized that a bioelectric dressing will reduce wound healing time when compared to SOC treatment, thereby accelerating wound healing trajectory.

" Walter Reed 's selection of Procellera® for a study of this significance is an exceptionally positive indicator for the future of Vomaris, and our proprietary bioelectric technology," said Michael P. Nagel , Vomaris President and CEO.

"Field experience along with our clinical studies continues to show that Procellera® has the potential to transform wound care as we know it today," Nagel said.  "Proving Procellera's impact in a study associated with the Combat Wound Initiative will provide another layer of critical clinical evidence and establish our cost-savings footprint in the emerging medical device marketplace."

Procellera® is the first totally self-contained, conformable, cut-to-fit, electrically active wound dressing in the world. The technology is extremely versatile and scalable and spans multiple indications.

For more information about Procellera®, please visit www.vomaris.com.

About Vomaris Innovations, Inc.
Vomaris Innovations, Inc., based in Chandler, Arizona, is a leading edge regenerative medical device company specializing in bioelectrical field generating technologies for the wound care market. FDA cleared, Procellera® is the world's first wireless, self-contained antimicrobial wound device that generates a sustained electrical microcurrent at the wound surface when activated with a conductive fluid. Procellera® is indicated for professional use for partial and full-thickness wounds such as pressure ulcers, venous ulcers, diabetic ulcers, burns, surgical incisions, and donor/recipient graft sites.  Randomized clinical trials are in process looking at other possible wound healing benefits for the use of Procellera®

For more information, visit www.vomaris.com or call 480.921.4948.


'/>"/>
SOURCE Vomaris Innovations, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Vomaris patent estate grows to six issued U.S. patents and three granted international patents with U.S. Pat. No. 8,224,439
2. Emergency Nurses Association Announces Corporate Sponsors for Leadership Conference
3. Neurim Pharmaceuticals Announces Positive Phase 2 Clinical Trial Results of Piromelatine for the Treatment of Insomnia
4. Aoxing Pharmaceutical Company, Inc. Announces Financial Results For Second Quarter Of 2013 Fiscal Year
5. Masimo Announces Adoption of Stock Repurchase Program
6. Odyssey Thera, Inc. Announces New Equity Financing and Initiation of Research Contract with Merck
7. HKTU Announces Development of a New Male Enhancement Supplement
8. STAAR Surgical Announces Fourth Quarter 2012 Results Release Date And Conference Call And Webcast
9. United Therapeutics Announces FDA Acceptance of Resubmission of Oral Treprostinil NDA
10. Breckenridge Announces Approval for Pioglitazone Hydrochloride tablets
11. Regulus Announces Timing for Fourth Quarter and Year-End 2012 Financial Results Webcast and Conference Call
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/17/2017)... 2017 Precision medicine is an emerging ... of disease. The approach allows doctors and physicians ... The approach studies the individual profile at a ... In January 2015, Precision Medicine Initiative (PMI) was ... with more than one million volunteers. All of ...
(Date:1/17/2017)... Pa. , Jan. 17, 2017 Secretary ... and Alcohol Programs Secretary Gary Tennis are ... carfentanil, following two recent overdose deaths from the drug ... "Carfentanil is intended to sedate large animals and ... kill anyone who comes into contact with it," Secretary ...
(Date:1/17/2017)... YORK , Jan. 17, 2017 EU5 ... GlobalData,s new report, "EU5 Glucose Monitoring Market Outlook ... Glucose Monitoring market. The report provides value, in millions ... (USD) within market segments - Blood Glucose Meters, Blood ... provides company shares and distribution shares data for each ...
Breaking Medicine Technology:
(Date:1/17/2017)... (PRWEB) , ... January 17, 2017 , ... ... SightMD – will lecture to primary eye care practitioners on the latest breakthroughs ... the upcoming 13th Semi-Annual Continuing Education Symposium, according to eye surgeon, Jeffrey Martin, ...
(Date:1/17/2017)... , ... January 17, 2017 , ... ... announced its partnership with Sigfox in the U.S.A. to offer Internet ... including new offerings on large-scale environmental sensor deployments such as monitoring solutions ...
(Date:1/17/2017)... CO (PRWEB) , ... January 17, 2017 , ... ... protection and financial planning assistance to families and business professionals throughout central Colorado, ... to regional homeless families. , The Aurora Warms The Night organization is committed ...
(Date:1/17/2017)... ... January 17, 2017 , ... Livionex, Inc., a Silicon Valley healthcare company focused ... study for its dental gel that shows significant reduction in plaque levels and gum ... The study was conducted at the Beckman Laser Institute at UC Irvine and has ...
(Date:1/17/2017)... ... January 17, 2017 , ... Physicians Education Review®, LCC ... keynote speaker for the 34th Annual Miami Breast Cancer Conference®, on March 9-12, ... president, Phil Talamo, said, “We are delighted to have Sandra Lee join us ...
Breaking Medicine News(10 mins):